Download MendeleyStructure of human endothelin-converting enzyme I complexed with phosphoramidon
Schulz, H., Dale, G.E., Karimi-Nejad, Y., Oefner, C.(2009) J Mol Biol 385: 178-187
- PubMed: 18992253
- DOI: https://doi.org/10.1016/j.jmb.2008.10.052
- Primary Citation of Related Structures:
3DWB - PubMed Abstract:
Endothelin-converting enzyme I (ECE-1) is a mammalian type II integral membrane zinc-containing endopeptidase. ECE-1 catalyzes the final step in the biosynthesis of endothelins in a rate-limiting fashion, through post-translational conversion of the biologically inactive big endothelins. Endothelin-1 overproduction has been implicated in a heterogeneous list of diseases including systemic and pulmonary hypertension, stroke and asthma, cardiac and renal failure. Therefore, ECE-1 is a prime therapeutic target for the regulation of endothelin-1 production in vivo and there is considerable interest in selective inhibitors of this enzyme. Here, we present the crystal structure of the extracellular domain (residues 90-770) of human ECE-1 (C428S) with the generic metalloprotease inhibitor phosphoramidon determined at 2.38 A resolution. The structure is closely related to that of human NEP, providing essential information for a detailed understanding of ligand-binding, specificity determinants as well as selectivity criteria. Selective inhibitors of ECE-1s should have beneficial effects for the treatment of diseases in which an overproduction of ETs plays a pathogenic role.
Organizational Affiliation:
Morphochem AG, Basel Switzerland.
